Literature DB >> 16537894

Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.

Mingming Zhao1, Justyna A Janas, Masaru Niki, Pier Paolo Pandolfi, Linda Van Aelst.   

Abstract

The Dok adaptor proteins play key regulatory roles in receptor and non-receptor kinase-initiated signaling pathways. Dok-1, the prototype member of this family, negatively regulates cell proliferation elicited by numerous growth factors, including platelet-derived growth factor (PDGF). However, how Dok-1 exerts its negative effect on mitogenesis has remained elusive. Using Dok-1 knockout cells and Dok-1 mutants deficient in binding to specific Dok-1-interacting proteins, we show that Dok-1 interferes with PDGF-stimulated c-myc induction and Ras/mitogen-activated protein kinase (MAPK) activation by tethering different signaling components to the cell membrane. Specifically, Dok-1 attenuates PDGF-elicited c-myc induction by recruiting Csk to active Src kinases, whereupon their activities and consequent c-myc induction are diminished. On the other hand, Dok-1 negatively regulates PDGF-induced MAPK activation by acting on Ras-GAP and at least one other Dok-1-interacting protein. Importantly, we demonstrate that Dok-1's actions on both of these signaling pathways contribute to its inhibitory effect on mitogenesis. Our data suggest a mechanistic basis for the inhibitory effect of Dok-1 on growth factor-induced mitogenesis and its role as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537894      PMCID: PMC1430334          DOI: 10.1128/MCB.26.7.2479-2489.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  61 in total

1.  Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase.

Authors:  Audrey Gérard; Cédric Favre; Fabien Garçon; Jean-Guy Némorin; Pascale Duplay; Sonia Pastor; Yves Collette; Daniel Olive; Jacques A Nunès
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

2.  Slap negatively regulates Src mitogenic function but does not revert Src-induced cell morphology changes.

Authors:  G Manes; P Bello; S Roche
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity.

Authors:  N Kashige; N Carpino; R Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases.

Authors:  M Kawabuchi; Y Satomi; T Takao; Y Shimonishi; S Nada; K Nagai; A Tarakhovsky; M Okada
Journal:  Nature       Date:  2000-04-27       Impact factor: 49.962

5.  Dok1 and SHIP act as negative regulators of v-Abl-induced pre-B cell transformation, proliferation and Ras/Erk activation.

Authors:  Shinji Oki; André Limnander; Pin Mei Yao; Masaru Niki; Pier Paolo Pandolfi; Paul B Rothman
Journal:  Cell Cycle       Date:  2005-02-04       Impact factor: 4.534

6.  SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling.

Authors:  R A Blake; M A Broome; X Liu; J Wu; M Gishizky; L Sun; S A Courtneidge
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

7.  p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction.

Authors:  S Suzu; M Tanaka-Douzono; K Nomaguchi; M Yamada; H Hayasawa; F Kimura; K Motoyoshi
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

8.  Growth-factor-dependent mitogenesis requires two distinct phases of signalling.

Authors:  S M Jones; A Kazlauskas
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

9.  Dok-1 tyrosine residues at 336 and 340 are essential for the negative regulation of Ras-Erk signalling, but dispensable for rasGAP-binding.

Authors:  Hisaaki Shinohara; Tomoharu Yasuda; Yuji Yamanashi
Journal:  Genes Cells       Date:  2004-06       Impact factor: 1.891

10.  c-Abl phosphorylates Dok1 to promote filopodia during cell spreading.

Authors:  Pamela J Woodring; Jill Meisenhelder; Sam A Johnson; Guo-Lei Zhou; Jeffrey Field; Kavita Shah; Friedhelm Bladt; Tony Pawson; Masaru Niki; Pier Paolo Pandolfi; Jean Y J Wang; Tony Hunter
Journal:  J Cell Biol       Date:  2004-05-17       Impact factor: 10.539

View more
  19 in total

1.  Dok-2 adaptor protein regulates the shear-dependent adhesive function of platelet integrin αIIbβ3 in mice.

Authors:  Sascha C Hughan; Christopher M Spring; Simone M Schoenwaelder; Sharelle Sturgeon; Imala Alwis; Yuping Yuan; James D McFadyen; Erik Westein; Duncan Goddard; Akiko Ono; Yuji Yamanashi; Warwick S Nesbitt; Shaun P Jackson
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

2.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

3.  Feedback circuits monitor and adjust basal Lck-dependent events in T cell receptor signaling.

Authors:  Jamie R Schoenborn; Ying Xim Tan; Chao Zhang; Kevan M Shokat; Arthur Weiss
Journal:  Sci Signal       Date:  2011-09-13       Impact factor: 8.192

4.  Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.

Authors:  Pierre-Luc Mercier; Magdalena Bachvarova; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Karim Ghani; Bernard Têtu; Isabelle Bairati; Dimcho Bachvarov
Journal:  Mol Oncol       Date:  2011-07-26       Impact factor: 6.603

5.  Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers.

Authors:  Amandine Saulnier; Thomas Vaissière; Jiping Yue; Maha Siouda; Marine Malfroy; Rosita Accardi; Marion Creveaux; Sinto Sebastian; Naveed Shahzad; Tarik Gheit; Ishraq Hussain; Mariela Torrente; Fausto Antonio Maffini; Luca Calabrese; Fausto Chiesa; Cyrille Cuenin; Ruchi Shukla; Ikbal Fathallah; Elena Matos; Alexander Daudt; Sergio Koifman; Victor Wünsch-Filho; Ana M B Menezes; Maria-Paula Curado; David Zaridze; Paolo Boffetta; Paul Brennan; Massimo Tommasino; Zdenko Herceg; Bakary S Sylla
Journal:  Int J Cancer       Date:  2011-09-22       Impact factor: 7.396

6.  CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens.

Authors:  Gaëtan Blaize; Hélène Daniels-Treffandier; Meryem Aloulou; Nelly Rouquié; Cui Yang; Marlène Marcellin; Mylène Gador; Mehdi Benamar; Mariette Ducatez; Ki-Duk Song; Odile Burlet-Schiltz; Abdelhadi Saoudi; Paul E Love; Nicolas Fazilleau; Anne Gonzalez de Peredo; Renaud Lesourne
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-20       Impact factor: 11.205

7.  Differential Regulation of RasGAPs in Cancer.

Authors:  Thomas Grewal; Meryem Koese; Francesc Tebar; Carlos Enrich
Journal:  Genes Cancer       Date:  2011-03

8.  Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling.

Authors:  Ramars Amanchy; Jun Zhong; Rosa Hong; James H Kim; Marjan Gucek; Robert N Cole; Henrik Molina; Akhilesh Pandey
Journal:  Mol Oncol       Date:  2009-07-10       Impact factor: 6.603

9.  Nt mutation causing laterality defects associated with deletion of rotatin.

Authors:  Bishwanath Chatterjee; Katharina Richards; Maja Bucan; Cecilia Lo
Journal:  Mamm Genome       Date:  2007-06-06       Impact factor: 2.957

10.  Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer.

Authors:  Audrey Sirvent; Christine Benistant; Serge Roche
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.